Subcutaneous treprostinil for the treatment of non-operable chronic thromboembolic pulmonary hypertension: a randomized, controlled trial (CTREPH)
Event:
ESC Congress 2017
Topic:
Chronic pulmonary hypertension
Session:
Progress in the management of pulmonary hypertension
